Edition:
United States

Chemed Corp (CHE)

CHE on New York Consolidated

203.43USD
21 Jul 2017
Change (% chg)

$0.09 (+0.04%)
Prev Close
$203.34
Open
$204.54
Day's High
$205.69
Day's Low
$202.35
Volume
102,719
Avg. Vol
93,807
52-wk High
$216.01
52-wk Low
$130.05

CHE

Chart for CHE

About

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians,... (more)

Overall

Beta: 1.15
Market Cap(Mil.): $3,271.60
Shares Outstanding(Mil.): 16.08
Dividend: 0.26
Yield (%): 0.51

Financials

  CHE Industry Sector
P/E (TTM): 29.86 30.22 15.85
EPS (TTM): 6.81 -- --
ROI: 16.10 7.17 -8.31
ROE: 23.08 11.55 -7.95

BRIEF-Chemed reports Q1 GAAP earnings per share $1.78

* Says revenue growth for vitas in 2017, prior to medicare cap, is estimated to be in range of 4% to 5%

Apr 26 2017

BRIEF-Chemed Corp CEO Kevin Mcnamara's 2016 compensation $6.5 mln

* Chemed corp - ceo kevin mcnamara's total compensation for 2016 was $6.5 million versus $7.4 million in 2015 - sec filing Source text for Eikon: Further company coverage:

Mar 31 2017

BRIEF-Chemed Corp board authorizes an additional $100 mln for stock repurchase

* Chemed Corp's board of directors authorizes an additional $100 million for stock repurchase

Mar 13 2017

BRIEF-CHEMED SETS QUARTERLY DIVIDEND OF $0.26 PER SHARE

* SETS QUARTERLY DIVIDEND OF $0.26 PER SHARE Source text for Eikon: Further company coverage:

Feb 17 2017

Earnings vs. Estimates